Co-Diagnostics, Inc. (LON:0A50)
2.290
-0.110 (-4.58%)
At close: Feb 11, 2026
Co-Diagnostics Revenue
Co-Diagnostics had revenue of $145.38K USD in the quarter ending September 30, 2025, a decrease of -77.32%. This brings the company's revenue in the last twelve months to $507.89K, down -93.06% year-over-year. In the year 2024, Co-Diagnostics had annual revenue of $3.92M, down -42.53%.
Revenue (ttm)
$507.89K
Revenue Growth
-93.06%
P/S Ratio
10.30
Revenue / Employee
$3.85K
Employees
132
Market Cap
3.89M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.92M | -2.90M | -42.53% |
| Dec 31, 2023 | 6.81M | -27.41M | -80.09% |
| Dec 31, 2022 | 34.22M | -63.67M | -65.04% |
| Dec 31, 2021 | 97.89M | 23.33M | 31.30% |
| Dec 31, 2020 | 74.55M | 74.34M | 34,579.90% |
| Dec 31, 2019 | 214.97K | 175.06K | 438.63% |
| Dec 31, 2018 | 39.91K | 32.25K | 420.90% |
| Dec 31, 2017 | 7.66K | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | 10.00K | - | - |
| Dec 31, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vox Valor Capital | 11.10M |
| World Chess | 1.96M |
| Supply@ME Capital | 177.00K |
| Sealand Capital Galaxy | 149.70K |
| Aterian | 62.00K |
| Thalassa Holdings | 27.74K |
| DeFi Development Corporation UK | 754.00 |
| British & American Investment Trust | -5.45M |